Cardiological effects of catecholamine-secreting tumours

European Journal of Clinical Investigation

Volumn 27, Issue 3, 1997, Pages 189-195

  Schurmeyer T H ^a,b   Engeroff, B ^b   Dralle, H ^c   Von Zur Muhlen A ^b  

^a UNIVERSITY OF TRIER   (Germany)

^b Abteilungen Klinische Endokrinologie   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

cardiac failure; catecholamines; echocardiography; electrocardiography; hypertensi on; phaeochromocytoma; symptoms

Indexed keywords

CATECHOLAMINE; NORADRENALIN;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

EID: 0030969669     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.850646.x     Document Type: Article

References (88)

1. Garcia R, Jennings JM. Pheochromocytoma masquerading as cardiomyopathy. Am J Cardiol 1972;29:568-71.
2. de Leeuu PW, Waltman FL, Birkenhager WH. Noncardiogenic pulmonary edema as the sole manifestation of pheochromocytoma. Hypertension 1986;810-12.
3. Yankopulos NA, Montera AC, Curd WG, Kahil ME, Condon RE. Observation on myocardial function during chronic catecholamine oversecretion. Chest 1974;66:585-7.
4. Kline IK. Myocardial alterations associated with pheochromocytomas. Am J Pathol 1961;38:539-47.
5. Rose AG. Catecholamine-induced myocardial damage associated with phaeochromocytomas and tetanus. S Afr Med J 1974;48:1285-9.
6. Cohen CD, Dent DM. Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction). Postgrad Med J 1984;60:111-15.
7. Baker G, Zellner NH, Weitzner S, Leach SK, Albuquerque NM. Pheochromocytoma without hypertension presenting as cardiomyopathy. Am Heart J 1972;83:688-93.
8. Goldbaum T, Henochowicz S. Pheochromocytoma presenting with Prinzmetal's angina. Am J Med 1986;81:921-2.
9. Kaul U, Mohan JC, Rao PS, Mukhopahyaya S, Sing SM. Bhatia ML. Pheochromocytoma presenting as recurrent syncope resulting from ventricular tachycardia - an unusual presentation. Ind Heart J 1984;36:118-20.
10. Martinez R, Russo R, Lupi M, Federici M. Cardiac involvement in pheochromocytoma. A report of 6 cases. Minerva Cardioangiol 1992;40:105-8.
11. Schürmeyer TH, Engeroff B, von zur Mühlen A, Dralle H. Symptomatik und endokrinologische Befunde bei katecholamin-sezernierenden Tumoren. Dtsch Med Wschr 1994;119:1721-7.
12. Ratge D, Baumgardt G, Knoll E, Wisser H. Plasma free and conjugated catecholamines in diagnosis and localisation of pheochromocytoma. Clin Chim Acta 1983;132:229-35.
13. Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 1985;109:568-74.
14. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;37:161-86.
15. Romhilt DW, Estes EH. A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968;75:752-8.
16. Murphy ML, Thenabadu PN, de Soyza N et al. Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy. Am J Cardiol 1984;53:1140-7.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58: 1072-83.
18. Boldt MH, Flexner M, Ortner AB. Pheochromocytoma associated with painless myocardial infarction. Ann Intern Med 1957;46: 1165-77.
19. Cheng TO. Pheochromocytoma as an MI mimic. Letter. Hosp Pract 1990;25:16.
20. Cheng TO, Bashour TT. Striking electrocardiographic changes associated with pheochromocytoma. Chest 1976;70:397-9.
21. Gupta KK. Phaeochromocytoma and myocardial infarction. Lancet 1975;1:281-2.
22. Mattman PE. Successful removal of a pheochromocytoma four weeks after acute myocardial infarction. Am J Cardiol 1961;8: 426-30.
23. McGonigle P, Webb SW, Adgey AAJ. Pheochromocytoma: an unusual cause of chest pain. Brit Med J 1983;286:1477-1478.
24. Nirgiotis JG, Andrassy RJ. Pheochromocytoma and acute myocardial infarction. South Med J 1990;83:1478-80.
25. Pelkonen R, Pitkanen E. Unusual electrocardiographic changes in pheochromocytoma. Acta Med Scand 1963;173:41-4.
26. Priest WM. Pheochromocytoma with fatal myocardial infarction in man aged 22. Br Med J 1952;2:860-2.
27. Wilkins RW, Greer WER, Culbertson JW et al. Extensive laboratory studies of a patient with pheochromocytoma before and after successful operation. Arch Intern Med 1950;86:51-78.
28. Yasue H, Touyama M, Kalo H, Tanaka S, Akiyama F. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documented by coronary arteriography. Am Heart J 1976;91:14-155.
29. Radtke WE, Kazmier FJ et al. Cardiovascular complication of pheochromocytoma crisis. Am J Cardiol 1975;35:701-5.
30. Salathe M, Weiss P, Ritz R. Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. Br Heart J 1992; 68:527-8.
31. Pogson WG, Sharma J, Crouch TT. Pulmonary edema with low-dose propranolol in pheochromocytoma. South Med J 1980;73: 795-8.
32. Robertson RM, Wood AJJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 1982; 65:281-5.
33. Sloand EM, Thompson BT. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med 1984;144:173-4.
34. Michaels RD, Hays JH, O'Brian JT, Shakir KM. Pheochromocytoma associated ventricular tachycardia blocked with atenolol. J Endocrinol Invest 1990;13:943-7.
35. Balazovjech I, Murin J, Kralova K. Catecholamine heart muscle disease in pheochromocytoma. Exp Clin Endocrinol 1989;93: 29-36.
36. Klein I, Ojamaa K. Clinical review 36: Cardiovascular manifestations of endocrine disease. J Clin Endocrinol Metab 1992;75: 339-42.
37. Salathe M, Romanens M, Weiss P, Ritz R. Acute left heart insufficiency: possible leading symptom of a pheochromocytoma. Schweiz Med Wochenschr 1992;122:597-600.
38. Jiang JP, Downing SE. Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med 1990; 63:581-91.
39. Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocytoma. New Engl J Med 1966;274:1102-8.
40. Pearce RM. Experimental myocarditis; a study of the histological changes following intravenous injections of adrenalin. J Exp Med 1906;8:400-9.
41. Szakacs JE, Mehlman B. Pathologic changes induced by 1-norepinephrine. Am J Cardiol 1960;5:619-27.
42. Franz G. Eine seltene Form von toxischer Myokardschädigung. Virchows Arch Pathol Anat 1937;298:743-52.
43. Raab W. The pathogenic significance of adrenalin and related substances in the heart muscle. Exp Med Surg 1943;1:188-225.
44. Hausmann M, Getzowa S. Ein Paragangliom des Zuckerkan-dl'schen Organs mit gleichzeitiger Herz- und Nierenhypertrophie. Schweizer Med Wochenschr 1922;52:889-92.
45. Sode J, Getzen LC, Osborn DP. Cardiac arrhythmias and cardiomyopathy associated with pheochromocytoma. Am J Surg 1967;114: 927-31.
46. Stecken F, Villeneuve A, Gauvain JB, Polin P, Therain F. Functional coronary insufficiency in pheochromocytoma. Contribution of isotopic tests. A case report. Arch Mal Coeur 1990;83: 1607-11.
47. Touze JE, Monnier A, Bordahandy R et al. Myocardite adrénergique mortelle au cours d'un phéochromocytome malin. Coeur 1983;14:435-9.
48. Wood R, Commerford PJ, Rose AG, Tooke A. Reversible catecholamine-induced cardiomyopathy. Am Heart J 1991;121: 610-13.
49. Burgess AM, Waterman GW, Cults FB. Adrenal sympathie syndrome with unusual variations in cardiac rhythm. Report of a case. Arch Intern Med 1936;58:433-47.
50. Cannon P, Sjöstrand T. ECG-changes seen in cases of pheochromocytoma compared with changes experimentally evoked by adrenaline. Scand J Clin Lab Invest 1952;4:266-7.
51. Durant J. Arrhythmic crisis of phaeochromocytoma. Lancet 1993;2:124-6.
52. Espersen T, Dahl-Iversen E. The clinical picture and treatment of pheochromocytomas of the suprarenal. Acta Chir Scand 1946;94: 271-90.
53. French C, Campagna FA. Pheochromocytoma with shock, marked leucocytosis, and unusual electrocardiograms. Case report and review of the literature. Ann Intern Med 1961;55:127-34.
54. Hegglin R, Holzmann M. Elektrokardiographische Befunde beim Paragangliom der Nebennieren. Dtsch Arch Klin Med 1937;180:681-91.
55. Mornex R, Perrin A, Saint-Pierre A, Peyrin L, Age C. Phéochromocytome avec troubles isolés du rythme cardiaque. Rev Lyon Med 1969;18:553-61.
56. Northfield TC. Cardiac complications of phaeochromocytoma. Br Heart J 1967;29:588-93.
57. Ouzts HG, Newland HR. Cardiac arrest in pheochromocytoma. Am Heart J 1982;103:923-4.
58. Saint-Pierre A, Lejosne C, Perrin A. Aspects électrocardiographiques des phéochromocytomes. Coeur Med Int 1975;13:59-73.
59. Sayer WJ, Moser M, Mattingly TW. Pheochromocytoma and the abnormal electrocardiogram. Am Heart J 1954;48:42-53.
60. Sierra-Callejas JL. Katecholamin-aktive Myokarditis bei Phäochromozytom. Dtsch Med Wochenschr 1974;99:2405-6.
61. Bucher HW, Aepli R, Zenger F, Stucki P. Phäochromozytom mit außergewöhnlichen Herzrhythmusstörungen und ihre Behandlung mit α- und β-Rezeptoren-Blockern. Schweizer Med Wschr 1969; 99:956-60.
62. Huang SK, Rosenberg MJ, Denes P. Short PR interval and narrow QR3 complex associated with pheochromocytoma: electrophysiologic observations. JACC 1984;3:872-5.
63. Abildskov JA. The prolonged QT interval. Annu Rev Med 1979; 30:171-9.
64. Stenström G, Swedberg K. QRS amplitude, QTc intervals and ECG abnormalities in pheochromocytoma patients before, during and after treatment. Acta Med Scand 1988;224:231-5.
65. Graham JB. Pheochromocytoma and hypertension. Int Abst Surg 1951;92:105-21.
66. Iizuka K, Makiguchi M, Suzuki Y. Postural ventricular tachycardia in patients with pheochromocytoma. Kokyu To Junkan 1991;39: 279-82.
67. Bramann HU, Zidek W, Vetter H. Long term ECG in pheochromocytoma. Cardiology 1985;72:163-5.
68. Dabrowska B, Feltynowski T, Wocial B, Szpak W, Januszewicz W. Effect of removal of phaeochromocytoma on diurnal variability of blood pressure, heart rhythm and excretion of catecholamines. J Hum Hypertens 1990;4:397-9.
69. Abildskov JA. Adrenergic effects on the QT interval of the electrocardiogram. Am Heart J 1976;92:210-16.
70. Barger AC, Herd JA, Liebowitz MR. Chronic catheterization of coronary artery: Induction of ECG pattern of myocardial ischemia by intracoronary epinephrine. Proc Soc Exp Biol Med 1961;107: 474-7.
71. Lepeschkin E, Marchet H, Schroeder G, Wagner R, de Paula e Silva P, Raab W. Effect of epinephrine and norepinephrine on the electrocardiogram of 100 normal subjects. Am J Cardiol 1960; 594-603.
72. Miller AJ, Cheng TO, Freeman ME. Electrocardiographic changes during norepinephrine-induced hypertension in normal man. Am Heart J 1956;50:567-76.
73. Tcherdakoff P, Simoni G, Milliez. P. Caractères évolutifs du phéochromocytome. Etude de 42 cas personnels. Nouv Press Méd 1974;3:861-4.
74. Sloan PJM, Beevers DG. Hypertension and the heart. A review. Eur Heart J 1983;4:215-22.
75. Mardini M. Echocardiographic findings in pheochromocytoma. Chest 1982;81:394-955.
76. Shub C, Cueto-Garcia L, Sheps SG, Ilstrup DM. Tajik AJ. Echocardiographic findings in pheochromocytoma. Am J Cardiol 1986;57:971-5.
77. Hicks RJ, Wood B, Kalff V, Anderson ST, Kelly MJ. Normalization of left ventricular ejection fraction following resection of pheochromocytoma in a patient with dilated cardiomyopathy. Clin Nucl Med 1991;16:413-16.
78. Schaffer M, Zuberbuhler P. Wilson G et al. Catecholamine cardiomyopathy: an unusual presentation of pheochromocytoma in children. J Pediatr 1981;99:276-9.
79. Scott I, Parkes R. Cameron DP. Phaeochromocytoma and cardiomyopathy. Med J Aust 1988;148:94-6.
80. Shapiro L, Trethowan N, Singh S. Normotensive cardiomyopathy and malignant hypertension in pheochromocytoma. Postgrad Med J 1982;58:110-12.
81. Fouad-Tarazi FM, Imamura M, Bravo EL et al. Differences in left ventricular structural and functional changes between pheochromo-cytoma and essential hypertension. Role of elevated circulating catecholamines. Am J Hypertens 1992;5:134-40.
82. Lee JC, Sponenberg DP. Role of α1-adrenoceptors in norepinephrine-induced cardiomyopathy. Am J Pathol 1985;121: 316-21.
83. Stenström G, Ernest I, Tisell LE. Long-term results in 64 patients operated upon for pheochromocytoma. Acta Med Scand 1988;223: 345-52.
84. Allen EV, Bannon WG, Upson M, Huizenga KA, Bastron JA, Waugh JM. A new sympatholytic and adrenolytic drug: clinical studies on pheochromocytoma and essential hypertension. Trans Assoc Am Physicians 1951;64:109-20.
85. Armstrong BK, Beahan PG, Leedman RL. Phaeochromocytoma with catecholamine cardiomyopathy successfully treated surgically. Aust N Z J Med 1972;4:402-4.
86. Hamada M, Ito T, Hiwada K, Kokubu T, Genda A, Takeda R. Characteristics of systolic time intervals in patients with pheochromocytoma. Jpn Circ J 1991;55:417-26.
87. Wiswell JG, Crago RM. Reversible cardiomyopathy with pheochromocytoma. Trans Clin Climat Assoc 1968;80:185-95.
88. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocrine Rev 1994;15:356-68.